UBS Group’s POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO XLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-29,149
Closed -$3.25M 8705
2018
Q1
$3.25M Buy
29,149
+1,491
+5% +$166K ﹤0.01% 2707
2017
Q4
$2.73M Buy
27,658
+7,660
+38% +$755K ﹤0.01% 2920
2017
Q3
$1.86M Buy
19,998
+3,427
+21% +$318K ﹤0.01% 3197
2017
Q2
$1.46M Buy
16,571
+335
+2% +$29.5K ﹤0.01% 3294
2017
Q1
$1.3M Sell
16,236
-6,595
-29% -$528K ﹤0.01% 3331
2016
Q4
$1.67M Sell
22,831
-7,976
-26% -$583K ﹤0.01% 3082
2016
Q3
$2.28M Sell
30,807
-1,571
-5% -$116K ﹤0.01% 2723
2016
Q2
$2.29M Buy
32,378
+826
+3% +$58.4K ﹤0.01% 2665
2016
Q1
$2.09M Sell
31,552
-22,091
-41% -$1.46M ﹤0.01% 2635
2015
Q4
$3.85M Buy
53,643
+15,316
+40% +$1.1M ﹤0.01% 2191
2015
Q3
$2.49M Buy
38,327
+5,664
+17% +$369K ﹤0.01% 2539
2015
Q2
$2.33M Sell
32,663
-22,328
-41% -$1.59M ﹤0.01% 2830
2015
Q1
$3.79M Buy
54,991
+2,258
+4% +$156K ﹤0.01% 2319
2014
Q4
$3.15M Buy
+52,733
New +$3.15M ﹤0.01% 2479

Other funds holding XLVS

UBS Group's XLVS Position: Q2 2018 in Review

UBS Group sold out of POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO (XLVS) in Q2 2018, closing a stake of 29,149 shares — an estimated $3.25M sold.

UBS Group first reported a position in XLVS in Q4 2014 and held it in 14 quarters. The position peaked at $3.85M in Q4 2015. 7 funds tracked by Wall St. Rank hold XLVS as of Q2 2018.

  • UBS Group reported no remaining POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO position as of Q2 2018 after selling out during the quarter.
  • UBS Group sold 29,149 POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO shares in Q2 2018, an estimated $3.25M.
  • UBS Group first reported a position in POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO in Q4 2014 and held it in 14 quarters.
  • UBS Group's POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO position peaked at $3.85M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO as of Q2 2018.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.